Categories AlphaGraphs, Earnings, LATEST, Technology

Apple Q3 Earnings: Profit, revenue beat estimates as iPhone recovery continues

Apple Inc. (NASDAQ: AAPL) on Tuesday published its third-quarter financial results, reporting stronger-than-expected numbers. Both sales and net profit increased in double digits as iPhone sales continued to recover from the recent slowdown.

Apple Q3 2021 earnings infographic

The Cupertino-based gadget giant said its third-quarter sales jumped 36% from last year to $81.4 billion. The growth was driven by a 50% surge in the sales of iPhone, the company’s flagship product. The top-line also came in above the consensus estimates.

Read management/analysts’ comments on Apple’s Q3 report

During the three-month period, net profit climbed to $21.7 billion or $1.30 per share from $11.3 billion or $0.65 per share in the third quarter of 2020, surpassing Wall Street’s expectations.

“This quarter, our teams built on a period of unmatched innovation by sharing powerful new products with our users, at a time when using technology to connect people everywhere has never been more important,” said Apple’s CEO Tim Cook.

iPhone quarterly sales growth trend

After an upbeat start to the year, Apple’s shares made strong gains and hit an all-time high earlier this month. The stock closed Tuesday’s regular trading lower.

Prior Performance

  • Apple Q3 2020 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Viewing Highlight